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Expression of the chemokine receptor CCR4 is strongly associated with trafficking of 
specialized cutaneous memory T helper (Th) lymphocytes to the skin. However, it is unknown 
whether CCR4 itself participates in the development of cutaneous Th populations. We have 
addressed this issue via competitive bone marrow (BM) reconstitution assays; equal numbers 
of BM cells from CCR4
 
 
 
/
 
 
 
 and CCR4
 
 
 
/
 
 
 
 donors were allowed to develop side-by-side within 
RAG-1
 
 
 
/
 
 
 
 hosts. Cells from both donor types developed equally well into B cells, naive CD8 T 
cells, naive CD4 T cells, interferon-
 
 
 
 
 
 Th1 cells, and interleukin-4
 
 
 
 Th2 cells. In marked 
contrast, circulating cutaneous memory Th cells (i.e., E-selectin ligand
 
 
 
 [E-lig
 
 
 
]) were more 
than fourfold more likely to be derived from CCR4
 
 
 
/
 
 
 
 donors than from CCR4
 
 
 
/
 
 
 
 donors. 
Most of this effect resides within the CD103
 
 
 
 subset of the E-lig
 
 
 
 Th population, in which 
donor CCR4
 
 
 
/
 
 
 
 cells can outnumber CCR4
 
 
 
/
 
 
 
 cells by 
 
 
 
12-fold. No similar effect was 
observed for 
 
 
 
4
 
 
 
7
 
 
 
 intestinal memory Th cells or CD103
 
 
 
/E-lig
 
 
 
 Th cells. We conclude that 
CCR4 expression provides a competitive advantage to cutaneous Th cells, either by 
participating in their development from naive Th cells, or by preferentially maintaining them 
within the memory population over time.
 
Each member of the Th lymphocyte population
expresses only a subset of the total adhesion mol-
ecule and chemoattractant receptor repertoires.
The specific “fingerprint” of these molecules
on a given lymphocyte determines the tissues
through which it can travel (1, 2). The two
best understood tissue-specific memory Th
subsets are distinguished by mutually exclusive
expression of the carbohydrate ligand for
E-selectin (E-lig; known as cutaneous lympho-
cyte-associated antigen in humans), which iden-
tifies cutaneous T cells, or the integrin 
 
 
 
4
 
 
 
7,
which identifies intestinal memory Th cells (1, 2).
Interaction of E-lig with endothelial E-selec-
tin  plays an important role the skin-homing
cascade (3, 4), whereas interaction of 
 
 
 
4
 
 
 
7
with endothelial mucosal addressin cell adhe-
sion molecule 1 plays a similar role in the gut
(2, 5, 6). Memory lymphocytes with receptors
for cutaneous antigens reside within the E-lig
 
 
 
population (4), whereas those with receptors
for intestinal antigens reside within the 
 
 
 
4
 
 
 
7
 
 
 
population (6). Adoptive transfer models
confirm that E-lig
 
 
 
 memory lymphocytes
home specifically to cutaneous sites and 
 
 
 
4
 
 
 
7
 
hi
 
memory lymphocytes home to intestinal sites
(2, 5, 6).
The chemokine receptor CCR4 is ex-
pressed by essentially all cutaneous Th cells in
human blood and skin, but is rarely found on
intestinal Th cells (7–9). Equally important,
one of the chemokine ligands for CCR4 (i.e.,
CCL17) is presented luminally by human cuta-
neous venules, but not by intestinal venules (7,
10). It is likely that CCR4–CCL17 interaction
contributes to skin-specific homing by trigger-
ing adhesion to endothelium (7). CCR4 is also
associated with cutaneous lymphocytes in the
mouse, as murine E-lig
 
 
 
 but not E-lig
 
 
 
 memory
Th cells respond to CCR4 ligands in chemo-
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taxis assays (11). The evolutionary pressure implied by main-
tenance of this association since the time when humans and
mice shared a common ancestor hints strongly at its biologi-
cal relevance.
Memory Th cells derive from naive Th cells that have
recognized antigen (for review see reference 2). Naive Th
cells express a limited, uniform fingerprint of trafficking
molecules, contrasting sharply with the diverse repertoires of
memory populations. The naive repertoire includes CD62L,
CCR7, and LFA-1 (for review see references 1, 2) and re-
stricts homing to lymphoid organs (1). Antigen is presented
to naive T cells by dendritic cells within lymphoid organs,
where dendritic cells orchestrate an “imprinting” process
(12). This entails that dendritic cells convey information re-
garding the tissue-specific origins of the antigens they carry
(12). Naive T cells receiving such information differentiate
into memory cells capable of homing to the type of tissue
from which the antigen originated (2). This scenario predicts
that naive Th cells recognizing antigen on cutaneous-derived
dendritic cells would differentiate into E-lig
 
 
 
/CCR4
 
 
 
 mem-
ory Th cells.
In the present report, we explore the possibility that CCR4
might itself play a role in cutaneous Th development. This no-
tion originates from the finding that Langerhans (cutaneous
dendritic) cells, after acquiring cutaneous antigens in vivo, se-
crete functional CCR4 ligands upon entering the draining
lymph node (13). However, initial studies suggested that
CCR4
 
   
 
 mice generate normal numbers of E-lig
 
 
 
 memory
Th cells (11). Despite this finding, there are two hypotheses
that might continue to support a role for CCR4 in this process.
First, CCR4 might play a redundant role with other molecules
compensating for its absence. Second, which we explore in this
report, CCR4
 
   
 
 mice may lack an important feature present
in normal animals: developmental competition between cells
lacking CCR4 and cells expressing CCR4.
Cyster et al. proposed that competition between individ-
ual lymphocytes controls their access to limited microenvi-
ronments in vivo (14). Such competition is a matter of life or
death if the microenvironment provides required signals for
continued survival and development. By creating in vivo
conditions where WT and CCR4
 
   
 
 cells compete during
memory Th differentiation, we ask whether the presence
and/or function of CCR4 might play a role in the develop-
ment of cutaneous memory Th populations.
 
RESULTS AND DISCUSSION
Competitive bone marrow reconstitution assay
 
Equal numbers of mixed BM cells (10
 
6
 
 each) from CCR4
 
   
 
and CCR4
 
   
 
 donors were injected i.v. into lethally irradi-
ated RAG-1
 
   
 
 hosts to create “experimental” BM chimeras
(BMCs). CCR4
 
   
 
 (i.e., WT) donors expressed the CD45.1
congenic marker, whereas CCR4
 
   
 
 donors expressed
CD45.2.
To control for potential differences in reconstitution effi-
ciency between CD45.1 and CD45.2 donor stem cells,
“control BMCs” were created in which both CD45.1 and
CD45.2 donors were WT. Pairs of control and experimental
BMCs were always created and harvested in parallel. Trans-
ferred BM cells were allowed to engraft the host for 6–12
wk before harvesting each BMC pair.
To assess the “engraftment efficiency” of each donor
type, we determined the CD45.1:CD45.2 ratio for a popula-
tion of BM-derived cells that would not be affected by
CCR4. B cells do not express CCR4 during their develop-
ment (7), so the CD45.1:CD45.2 ratio was determined for
splenic B cells in each BMC. This ratio ranged from 0.50 to
1.53 for 16 BMCs and was not significantly different be-
tween control and experimental BMCs. This confirms that
CCR4 deficiency does not compromise donor cell engraft-
ment, nor does it compromise B cell development. Thus, for
each mouse, the CD45.1:CD45.2 ratio for each T cell popu-
lation studied were corrected for engraftment efficiency to
yield 
 
R
 
 by the formula:
 
CCR4 deficiency does not influence development of naive, 
Th1, or Th2 T subsets
 
R
 
 was next determined for naive CD4 and CD8 splenic T
cells (Fig. 1 a). There were no significant differences in 
 
R
 
between control (Fig. 1 b, white bars) and experimental
BMCs (Fig. 1 b, black bars). The findings were identical for
naive T cells from PLNs, MLNs, and PBLs (unpublished
data). These results suggest that CCR4 function is not in-
volved in the development of naive T cells. In addition, no
significant differences were seen in 
 
R
 
 between experimental
and control BMCs for neutrophils, NK cells, or any of the
major thymic subsets (Fig. S1, available at http://www.jem.
org/cgi/content/full/jem.20041059/DC1).
CCR4 has been proposed as a marker for cultured T
cells polarized to produce Th2 cytokines (15). We used the
competitive assay to assess the influence of CCR4 on Th1
and Th2 development in vivo. PLNs and spleen cells from
BMCs were treated briefly with PMA, ionomycin, and
brefeldin A to induce intracellular cytokine accumulation.
Treated cells were stained for CD4 and congenic CD45
markers, plus intracellular IFN-
 
 
 
 and IL-4 (Fig. 1 c). There
were no significant differences in 
 
R
 
 between control BMCs
(Fig. 1 d, white bars) and experimental BMC (Fig. 1 d, black
bars), suggesting that CCR4 function does not influence the
development of Th1 or Th2 populations in vivo.
 
A role for CCR4 in development of tissue-specific 
Th memory populations
 
We found that memory Th cells expressing E-lig or 
 
 
 
4
 
 
 
7
could be clearly identified in the PBLs of our BMCs (Fig. 2
a) as previously reported for humans (2). This suggests that
normal tissue-specific memory Th development can occur
in our BMCs. Interestingly, we found a dramatic (greater
than fourfold) increase in 
 
R
 
 for E-lig
 
 
 
 memory Th cells be-
tween experimental and control BMCs (Fig. 2 b, top; P 
 
 
R
CD45.1:CD45.2 () specific T cell pop
CD24.1:CD45.2 () B cell
------------------------------------------------------------------------ . = 
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0.009). In contrast, we found only a small (but significant)
1.5-fold increase in 
 
R
 
 for 
 
 
 
4
 
 
 
7
 
 
 
 Th cells between experi-
mental and control BMCs. The difference in 
 
R
 
 between
E-lig
 
 
 
 and 
 
 
 
4
 
 
 
7
 
 
 
 Th cells from experimental, but not control,
BMCs was highly significant (P 
 
  
 
0.04). E-lig
 
 
 
 Th memory
cells from PLNs, where 
 
 
 
4
 
 
 
7
 
 
 
 Th memory cells were too
rare for analysis, showed a similarly dramatic difference in 
 
R
 
between experimental and control BMCs (Fig. 2 b, bottom).
These findings suggest a role for CCR4 function in develop-
ment of the mature circulating cutaneous Th population.
 
The CCR4 effect resides primarily within the E-lig
 
 
 
/CD103
 
 
 
 
Th population
 
A large percentage of intradermal T cells in humans (like in-
traepithelial T cells in many organs) express the integrin 
 
 
 
E
(CD103), as a heterodimer with 
 
 
 
7. The 
 
 
 
E
 
 
 
7 dimer is
thought to participate in lymphocyte retention within epi-
thelium via its ligand E-cadherin (16). Therefore, CD103
expression by E-lig
 
 
 
 mouse T cells may indicate their recent
residence within the skin (17).
We detected a large number of E-lig
 
 
 
/CD103
 
 
 
 Th cells
within the PLNs of our BMCs (Fig. 2 c, bottom) as de-
scribed previously (17). We also observed a significant popu-
lation of E-lig
 
 
 
/CD103
 
 
 
 Th cells within the PBLs (Fig. 2 c,
top). The difference in 
 
R
 
 between control and experimental
BMCs was significantly larger for the E-lig
 
 
 
/CD103
 
 
 
 Th
population than for the E-lig
 
 
 
/CD103
 
 
 
 Th population (Fig.
2 d), reaching a 5:1 ratio. There was no effect on the E-lig
 
 
 
/
CD103
 
 
 
 population, showing this not to be a general effect
on CD103
 
 
 
 memory Th cells (Fig. 2 d). Results were simi-
lar for both PBLs Th cells (Fig. 2 d, top) and PLN Th cells
(Fig. 2 d, bottom).
 
Other subsets of E-lig
 
 
 
 Th cells
 
Next, we examined E-lig  Th subsets defined by markers
other than CD103 (Fig. 3). We distinguished subsets by the
Treg marker CD25 (Fig. 3, top center), or by the presence of
intracellular IFN  (i.e., cutaneous Th1 cells; Fig. 3, top right).
E-lig  cells producing IL-4 (i.e., cutaneous Th2) were not
present in sufficient quantities to assess R (unpublished data).
The Rs were significantly greater for experimental versus con-
trol chimeras in all E-lig  populations, but not in any of the
E-lig  populations. CD103-defined subsets were included for
comparison (Fig. 3, top left). The Rs for E-lig /CD103 ,
E-lig /CD103 , and E-lig /CD103  cells were similar to that
seen previously in Fig. 2 d. In contrast, the R was not signifi-
cantly different between E-lig /CD25  and E-lig /CD25 
populations (Fig. 3, top middle), showing that absence of
CCR4 affected both populations equally. The difference in R
was also insignificant between E-lig /IFN   and E-lig /
IFN   populations (Fig. 3, top right). Thus, the effect of
CCR4 on cutaneous Th development resides mostly within
Figure 1. CCR4 deficiency does not influence development of 
naive, Th1, or Th2 T cells. (a) Identification of naive CD4  (CD45RBhi/
CD44lo) and naive CD8  (CD44lo/PNAlo) T cell populations. (b) Transplanted 
CCR4    bone marrow develops into naive T cells with the same efficiency 
as competing WT cells in BMCs, as there is no significant difference in the 
R for naive T splenocytes. Data from spleens of eight BMC pairs (mean   
SEM). (c) Intracellular staining for IL-4 and IFN-  CD4  lymphocytes used 
for identification of IL-4  Th2 and IFN-   Th1 cells in the BMCs. (d) CD4  
cells in experimental BMCs show no significant difference in the R com-
pared with control BMCs. Data from five BMC pairs (mean   SEM).CCR4 AND THE DEVELOPMENT OF CUTANEOUS T CELL POPULATIONS| Baekkevold et al. 1048
the CD103  subset and is evenly distributed among CD25 ,
CD25 , IFN  , and IFN   Th subsets.
E-lig  Th subsets during cutaneous inflammation
Next, we asked whether CCR4 influenced development of
the aforementioned populations during cutaneous inflamma-
tion. We induced contact hypersensitivity by challenging the
ears of presensitized mice with OVA323-339 peptide and har-
vesting the cervical PLNs on day 5. The R for E-lig /
CD103  was dramatically greater for challenged versus un-
challenged experimental BMCs (13 vs. 6; P   0.05; com-
pare Fig. 3, left, top and bottom). There was no significant
difference for subsets defined by CD25 or IFN . Thus, R
was dramatically increased in the E-lig /CD103  population
during cutaneous inflammatory responses, but unchanged in
those populations defined by CD25 and IFN . This inflam-
matory model did not produce significant numbers of E-lig 
Th2 cells (unpublished data).
Expression of functional CCR4 by Th subsets
One testable explanation for the differences between E-lig /
CD103  and E-lig /CD103  populations might be that
CCR4 is only expressed by the CD103  cutaneous Th sub-
set. Therefore, we assessed the ability of each population
(from WT) to respond to a CCR4 ligand in chemotaxis as-
says (7, 11, 18). Naive Th cells from PBLs (Fig. 4 a, left) or
PLN (right) had no appreciable increase in migration to
CCL22 (black bars) over medium alone (gray bars). Both
E-lig /CD103  and E-lig /CD103  Th cells responded
robustly to CCL22, suggesting that both populations are
likely to express high levels of CCR4. All three Th subsets
responded equally well to the more universal chemoattrac-
tant CXCL12, a ligand for CXCR4 (Fig. 4 a, white bars).
Expression of E-lig and CD103 by Th cells from 
unmanipulated WT and CCR4 /  mice
As reported previously, CCR4    mice possess normal pro-
portions of E-lig  memory Th cells (11). We have con-
firmed this finding for PLNs (Fig. 4 b, bottom left) and
shown that it is also true for PBLs (Fig. 4 b, top left). Fur-
thermore, we show that CCR4    mice have identical pro-
portions of CD103  cells within their E-lig  Th populations
in both PLNs (Fig. 4 b, bottom right) and PBLs (top right).
The fact that normal numbers of E-lig  Th cells are
found within unmanipulated CCR4    mice indicates that
their naive cells are fully capable of differentiating into
E-lig /CD103  and E-lig /CD103  Th cells. However, in
the presence of competing WT cells, the CCR4    cells are
less likely to be found within these populations. Thus, al-
though clearly capable of differentiating into E-lig  Th sub-
sets, CCR4    cells are less efficient at doing so than WT
cells. The effect is not observable in the unmanipulated
CCR4    mice because we are seeing only a snapshot of a
developmental process that has already reached a steady state;
although less efficient at becoming E-lig  Th cells than WT
cells, CCR4    cells, when given enough time and pro-
tected from competition with normal cells, can form an
E-lig  Th pool that appears normal. Unlike the unmanipu-
lated CCR4    mice, the chimeric mice provide an environ-
ment in which such competition can occur, mimicking the
normal developmental environment of cutaneous Th cells.
The role of CCR4 in generating cutaneous Th populations
Tang and Cyster demonstrated that Langerhans cells that
have recently acquired cutaneous antigen secrete functional
Figure 2. CCR4 participates in generation of cutaneous CD4  
memory Th populations. (a) Identification of tissue-tropic PBL Th cell 
populations. CD4  T cells analyzed by FACS for E-lig (skin memory cells) or 
 4 7 integrin (intestinal memory cells) together with the naive Th marker 
CD45RB. (b) In PBLs, experimental chimeras show a highly increased R 
compared with control chimeras. This was significantly higher than that of 
 4 7  cells. Data from 6 and 10 BMC pairs are shown for PBLs and PLNs, 
respectively (mean   SEM). (c) FACS analysis of PBLs and PLNs show that 
E-lig  memory cells are separated into two subpopulations based CD103 
expression. (d) Experimental chimeras show a significantly larger difference 
in R for the E-lig /CD103  Th population than for the E-lig /CD103  popu-
lation. However, R within the E-lig /CD103  Th population shows no sig-
nificant alteration between experimental and control chimeras. Data from 
15 BMC pairs (mean   SEM).JEM VOL. 201, April 4, 2005 1049
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CCR4 ligands upon entry into draining LNs (13). This
could suggest that CCR4 ligands are part of the dendritic
cell signaling event that “imprints” naive Th cells to become
cutaneous memory Th cells. Although CCR4 is not ob-
served on naive Th cells (Fig. 4 a and references 2, 7–9, 11),
it is certainly possible that naive Th cells express CCR4 at
levels below detectability that can nonetheless transduce an
effective differentiation signal.
Alternatively, CCR4 may influence proliferation or con-
tinued viability of E-lig  cells after differentiation. Memory
cell clonal lineages that repeatedly encounter antigen are
likely to proliferate over time. In contrast, memory cells that
never again encounter antigen after initial differentiation
would remain only at low numbers, if maintained at all. If, as
we have previously proposed (7), CCR4 plays a role in entry
of Th cells into cutaneous sites from the blood, E-lig  Th
cells lacking CCR4 may have difficulty entering cutaneous
sites, especially in the presence of competing WT cells. Thus,
E-lig /CCR4  Th cells would be more likely to reencoun-
ter cutaneous antigens than E-lig /CCR4  Th cells. Mem-
ory Th cells recognizing cutaneous antigens but incapable of
homing to skin would eventually be outnumbered by fully
functional WT cutaneous Th cells. We feel that this latter in-
terpretation is the most likely because the effects of CCR4
deficiency are most pronounced in the CD103  population
and are greatly amplified during inflammation. As CD103 is a
Figure 3. Comparison of E-lig  Th subsets defined by CD103, 
CD25, and IFN  before and after cutaneous inflammation. BMCs 
were sensitized to OVA323-339. PLNs were isolated from “unchallenged 
mice” (top row) or from “challenged mice” (bottom row) were harvested 
on day 5 after challenge. Data represent mean and SD from five unchallenged 
(top row) and four challenged BMC pairs (bottom row).
Figure 4. Comparison of memory Th populations from unmanipu-
lated WT and CCR4 /  mice. (a) Both E-lig /CD103  and E-lig /CD103  
populations express functional CCR4. Lymphocytes were isolated from 
PBLs and PLNs, and migrated to medium alone (gray bars), the CCR4 
ligand CCL22 (black bars), or the CXCR4 ligand CXCL12 (white bars) in 
transwells. The data (mean   SEM) are from four independent experiments 
with four to eight transwells per data point per experiment. (b) Both WT and 
CCR4 /  mice have similar numbers of E-lig  cells in their PBL and PLN Th 
populations (left). Furthermore, there is no difference in the proportion of 
cutaneous Th cells expressing CD103 between the two genotypes (right).CCR4 AND THE DEVELOPMENT OF CUTANEOUS T CELL POPULATIONS| Baekkevold et al. 1050
marker of intradermal T cells, it is possible that its expression
requires a further differentiation signal to cells that have al-
ready been committed to the cutaneous Th lineage. In light
of our findings, it is possible that this further signal might re-
quire actual trafficking of E-lig  Th cells to the skin.
E-lig /CD103  Th cells are known to be greatly enriched
in Treg activity when compared with E-lig /CD103  Th
cells (17). However, we did not see a similar effect when as-
sessing E-lig /CD25  Th cells in parallel.
It is noteworthy that E-lig  Th1 cells and other E-lig 
Th cells are similarly affected by CCR4 deficiency. In vitro
studies of polarized Th cultures suggested that CCR4 was a
marker of Th2 rather than Th1 cells (15). According to the
data presented here, the influence of CCR4 on Th develop-
ment depends more on the cutaneous homing profile of a
given Th cell, rather than its Th1 or Th2 status.
Conclusions
We have tested the ability of CCR4    BM cells to differen-
tiate in vivo into various lymphocyte subtypes when devel-
oping in the presence of equal numbers of WT BM cells.
We found that CCR4    and WT donor cells develop
equally well into B cells, naive CD4  T cells, naive CD8  T
cells, Th1 cells, and Th2 cells. In contrast, CCR4    cells do
not develop equally well into E-lig  memory Th cells, with
WT cells outnumbering CCR4    cells 13:1 within the
CD103 /E-lig  population during cutaneous inflammation.
Our findings suggest that chemokine receptor function can
strongly influence the development of mature tissue-specific
memory lymphocyte populations.
MATERIALS AND METHODS
Mice.  C57Bl/6N (Charles River Laboratories); RAG-1    and B6.SJL-
ptprc(a)Pep3(b)BoyJ (WT, CD45.1   ; The Jackson Laboratory); CCR4   
(11) maintained in our own facility on C57Bl/6N background.
Chimeric mice. WT, CD45.1   , WT, CD45.2   , and CCR4   ,
CD45.2    mice were killed at 4–7 wk, and BM was prepared as described
previously (19) and mixed at a 1:1 ratio: WT, CD45.1 /     WT,
CD45.2 /    “control BMC”; and WT, CD45.1      CCR4   ,
CD45.2       “experimental BMCs.” 2   106 BM cells were injected
retro-orbitally to anesthesized RAG-1    recipients after 2   600 rad
X-irradiation. Drinking water contained antibiotics for the first 2 wk. Ani-
mals were killed 6–12 wk after reconstitution, and suspensions were pre-
pared from PLNs, MLNs, and spleen by gentle disruption through nylon
mesh. Blood was drawn by cardiac puncture, and PBLs were purified on
Lympholyte Mammal (Cedar Lane). Animal experiments were approved by
the Animal Care and Use Committee of Children’s Hospital, Boston.
Flow cytometry.  The following conjugated MAbs were used: CD45.1-
FITC or -PE, CD45RB-PE, CD19-PE, CD4-PECy7, CD8-PECy7,
CD44-allophycocyanin, CD62L-allophycocyanin, CD103-PE, and CD25-
PE (all obtained from BD Biosciences).  4 7 was detected with DATK32
(BD Biosciences), followed by biotinylated goat anti–rat IgG (Caltag), and
streptavidin-Cy5 (Jackson ImmunoResearch Laboratories). Recombinant
murine E-selectin IgG chimeric molecules (R&D Systems) was followed by
Cy2 goat anti–human IgG (Jackson ImmunoResearch Laboratories).
Cytokine single cell analysis was performed as described previously
(20). Cells were activated 5 h with 50 ng/ml PMA and 1  M ionomycin
with 10  g/ml brefeldin-A (all obtained from Sigma-Aldrich). Cells were
fixed and permeabilized with Fix & Perm kit (Caltag) and stained with anti–
IL4-PE and anti–IFN -allophycocyanin together with anti-CD4 PECy7
and anti-CD45.1–FITC (all from BD Biosciences). Cells were analyzed on
a dual-laser MoFlo cytometer (DakoCytomation) configured for six colors
with Summit 3.1 software.
Chemotaxis.  PLNs and PBLs were obtained from ten 4–6 wk C57Bl/
6N mice as described before. Migration was performed as described previ-
ously (7, 11, 18) with four to eight replicates for each chemokine or con-
trol. Optimal chemokine concentrations were used as determined previ-
ously: 100 nM for murine CCL22 (R&D Systems) and 30 nM for CXCL12
(Gryphon).
Induction of contact hypersensitivity. Stratum corneum was gently
stripped from mouse ears with adhesive tape, and cutaneous lipids were re-
moved with acetone as described previously (21). Each prepared ear was
painted with an aqueous mixture of 25  g cholera toxin (List Biologicals)
and 200  g OVA323-339 (AnaSpec). This procedure was repeated three times
at 10-d intervals for all mice presented in Fig. 3. PLNs from unchallenged
mice were harvested 15–25 d after the third topical immunization. Chal-
lenged mice were given a fourth topical immunization 15–25 d after the
third, and cervical LNs were harvested on day 5. Cervical LNs were appre-
ciably larger in challenged versus unchallenged mice (unpublished data).
Statistical analysis.  For statistical comparison of two samples, a two-
tailed Student’s t test was used when applicable.
Online supplemental material. Additional experiments demonstrate
that there are no significant differences in R between experimental and con-
trol BMCs for several more leukocyte populations. These include periph-
eral blood neutrophils, spleen NK cells, and each of the four major thymic
subsets. Online supplemental material is available at http://www.jem.org/
cgi/content/full/jem.20041059/DC1.
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